Follow
Twan Lammers
Twan Lammers
Professor of Medicine, RWTH Aachen
Verified email at ukaachen.de - Homepage
Title
Cited by
Cited by
Year
Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress
T Lammers, F Kiessling, WE Hennink, G Storm
Journal of controlled release 161 (2), 175-187, 2012
13882012
Challenges and strategies in anti-cancer nanomedicine development: An industry perspective
JI Hare, T Lammers, MB Ashford, S Puri, G Storm, ST Barry
Advanced drug delivery reviews 108, 25-38, 2017
8962017
Tumor targeting via EPR: Strategies to enhance patient responses
SK Golombek, JN May, B Theek, L Appold, N Drude, F Kiessling, ...
Advanced drug delivery reviews 130, 17-38, 2018
8882018
Theranostic nanomedicine
T Lammers, S Aime, WE Hennink, G Storm, F Kiessling
Accounts of chemical research 44 (10), 1029-1038, 2011
8802011
Tumour-targeted nanomedicines: principles and practice
T Lammers, WE Hennink, G Storm
British journal of cancer 99 (3), 392-397, 2008
6562008
Smart cancer nanomedicine
R van der Meel, E Sulheim, Y Shi, F Kiessling, WJM Mulder, T Lammers
Nature nanotechnology 14 (11), 1007-1017, 2019
6382019
Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications
SM Dadfar, K Roemhild, NI Drude, S von Stillfried, R Knüchel, F Kiessling, ...
Advanced drug delivery reviews 138, 302-325, 2019
6092019
Nanotheranostics and image-guided drug delivery: current concepts and future directions
T Lammers, F Kiessling, WE Hennink, G Storm
Molecular pharmaceutics 7 (6), 1899-1912, 2010
4362010
Core-crosslinked polymeric micelles: Principles, preparation, biomedical applications and clinical translation
M Talelli, M Barz, CJF Rijcken, F Kiessling, WE Hennink, T Lammers
Nano today 10 (1), 93-117, 2015
4352015
Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner
C Zhang, M Jugold, EC Woenne, T Lammers, B Morgenstern, MM Mueller, ...
Cancer research 67 (4), 1555-1562, 2007
4232007
Applications of nanoparticles for diagnosis and therapy of cancer
SC Baetke, T Lammers, F Kiessling
The British journal of radiology 88 (1054), 20150207, 2015
4032015
Noninvasive imaging of nanomedicines and nanotheranostics: principles, progress, and prospects
S Kunjachan, J Ehling, G Storm, F Kiessling, T Lammers
Chemical reviews 115 (19), 10907-10937, 2015
3962015
The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy
Y Shi, R Van der Meel, X Chen, T Lammers
Theranostics 10 (17), 7921, 2020
3382020
Passive versus active tumor targeting using RGD-and NGR-modified polymeric nanomedicines
S Kunjachan, R Pola, F Gremse, B Theek, J Ehling, D Moeckel, ...
Nano letters 14 (2), 972-981, 2014
3292014
Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications
LY Rizzo, B Theek, G Storm, F Kiessling, T Lammers
Current opinion in biotechnology 24 (6), 1159-1166, 2013
3282013
Ultrasound microbubbles for molecular diagnosis, therapy, and theranostics
F Kiessling, S Fokong, P Koczera, W Lederle, T Lammers
Journal of nuclear medicine 53 (3), 345-348, 2012
3242012
PLGA-based nanoparticles in cancer treatment
S Rezvantalab, NI Drude, MK Moraveji, N Güvener, EK Koons, Y Shi, ...
Frontiers in pharmacology 9, 1260, 2018
3072018
Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers
T Lammers, V Subr, K Ulbrich, P Peschke, PE Huber, WE Hennink, ...
Biomaterials 30 (20), 3466-3475, 2009
2752009
Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin
M Talelli, M Iman, AK Varkouhi, CJF Rijcken, RM Schiffelers, T Etrych, ...
Biomaterials 31 (30), 7797-7804, 2010
2732010
Multidrug resistance: Physiological principles and nanomedical solutions
S Kunjachan, B Rychlik, G Storm, F Kiessling, T Lammers
Advanced drug delivery reviews 65 (13-14), 1852-1865, 2013
2542013
The system can't perform the operation now. Try again later.
Articles 1–20